Alzheimer Disease Clinical Trial
— Tele-STELLAOfficial title:
Using Technology to Support Care Partners for Persons With Alzheimer's Disease: Tele-STELLA
The purpose of this study is to test a revised psychoeducational intervention to help Care Partners for family members with dementia understand and reduce the distressing behaviors that come with progressive dementia. Tele-STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent videoconference-based intervention designed to facilitate effective management of behavioral and psychological symptoms common to the later stages of dementia. In the Tele-STELLA intervention, professionals ("Guides") meet with family members ("Care Partners") who care for persons with dementia. Working together, the Care Partners and Guides identify strategies to address upsetting behaviors. The goal of this intervention is to reduce upsetting behaviors and, thus, Care Partner burden.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | January 15, 2026 |
Est. primary completion date | January 15, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Care Recipient Inclusion Criteria: - Diagnosis of ADRD, moderate to late stages as defined by family member (Box 1) - Exhibits 2 or more behaviors listed on RMBPC that are bothersome to the Care Partner and occur 3 or more times/week at study enrollment - Family member of Care Partner (this can be a relative, spouse or close kin that is considered family) Care Recipient Exclusion Criteria: - Dementia not related to ADRD - Unable to leave Care Partner during Tele-STELLA sessions - Early stage dementia, as defined by family member Care Partner Inclusion Criteria: - Adult caring for family member with ADRD - Provides care for at least 4 hours/week - Age of 18 years or older - Speaks and understands English to be able to participate in intervention - Owns a telephone (smartphone, cell phone or landline) - Has mailing address to receive computer and study materials - Provides informed consent to participate in the Research Care Partner Exclusion Criteria: - Unable to find activity for care recipient during Tele-STELLA sessions to allow Care Partner to work privately with Guide and other Care Partners. - Completed similar telehealth intervention within the last year - Hearing and/or vision problems severe enough to prevent participation - Unwilling or unable to adequately follow study instructions and participate in study procedures |
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Lindauer A, Messecar D, McKenzie G, Gibson A, Wharton W, Bianchi A, Tarter R, Tadesse R, Boardman C, Golonka O, Gothard S, Dodge HH. The Tele-STELLA protocol: Telehealth-based support for families living with later-stage Alzheimer's disease. J Adv Nurs. 2021 Oct;77(10):4254-4267. doi: 10.1111/jan.14980. Epub 2021 Jul 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Revised Memory and Behavior Problems Checklist | Care partner difficulty in managing behavioral symptoms of dementia. 24-item caregiver report measure, 5-point Likert scale, higher scores mean greater behavioral problems. | 12 Months | |
Secondary | Marwit Meuser Caregiver Grief Index-Short Form | Care partner pre-death grief. 18-item caregiver report measure. 5-point Likert scale. Higher scores mean greater grief. | 12 Months | |
Secondary | Quality of Life in Alzheimer's Disease | Quality of life of care partners and care recipients | 12 Months | |
Secondary | Center for Epidemiological Studies Depression Scale | Care partner depression. 20-item caregiver report measure. 4-point Likert scale. Higher scores mean greater depression. | 12 Months | |
Secondary | Out of pocket costs | Weekly survey of costs | 12 months | |
Secondary | Health care use survey | Weekly survey of health care use | 12 months | |
Secondary | 4 item Zarit Burden Interview | Care partner burden. 4-item caregiver report measure, 5-point Likert scale, higher scores mean greater burden. | 12 Months | |
Secondary | Ten Item Personality Inventory | Assesses introversion/extraversion | 6 months | |
Secondary | Computer Self-Efficacy and Computer Anxiety Survey | Assesses comfort with computers | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |